
ACR’s Recommendations for Controlling Drug Costs, Improving Outcomes
Originally published in Rheumatology Network Affordability is a leading cause of drug abandonment among rheumatology patients. Out-of-pocket costs can be substantial. For example, rheumatoid arthritis